Published by Oxford University Press, 1998
ISBN 10: 1841100064 ISBN 13: 9781841100067
Seller: CorgiPack, Fulton, NY, U.S.A.
Hardcover. Condition: VG. Text free of underlining, writing and highlighting. Alzheimer's disease (AD) is a progressively degenerative form of dementia in which impaired cognitive functioning is the earliest and most prominent clinical 'symptom'. While much has been learned about the disease process itself, progress in treatment has been slow and the search for new and more effective therapies is intensifying rapidly. This book critically assesses the impact of the next generation of drug treatments in AD. It will serve as a valuable reference source for clinical researchers involved in all aspects of drug development in AD including neurologists, psychiatrists, geriatricians, psychologists, psychopharmacologists, clinical pharmacologists and all those involved in the design and analysis of pharmaceutical trials. ' 208 pages.